A 28-year-old male is experiencing hairline recession despite his family having full heads of hair. Suggested treatments include finasteride, minoxidil, and ketoconazole 2% shampoo.
Hairloss treatments like Minoxidil, finasteride, and stem cell therapies exist, but a complete cure is hindered by genetic complexity and market dynamics. Cloning hair follicles is considered a potential solution, but it's currently not feasible.
The conversation discusses hairloss concerns, with suggestions to use finasteride (Fin) and minoxidil (Min) as treatments. Stress, creatine in protein shakes, and male pattern baldness are considered potential factors.
The conversation discusses potential future hairloss treatments, including SCUBE3, hair follicle cloning, and GT20029, with mentions of past disappointments like CosmeRNA and hopes for treatments like Verteporfin for infinite donor hair.
Hairloss treatments, including PP405, minoxidil, finasteride, and RU58841, with hopes for future solutions. Participants discuss the emotional impact of hairloss and consider alternatives like hair transplants or acceptance.
A 21-year-old experiencing hairloss was prescribed two shampoos and hair vitamins by a dermatologist who suggested seborrheic dermatitis as the cause. However, users in the conversation suggested the hairloss could be male pattern baldness (MPB), recommending monitoring the situation and considering finasteride as a treatment.
The conclusion of the conversation is that the user has tried various medications and treatments for hairloss, including minoxidil, finasteride, microneedling, and nizoral shampoo, but has not seen any progress. They have decided to shave their head. Other users suggest options such as hair transplants, RU58841, hair units, and scalp micropigmentation.
Hair multiplication or cloning is not available anywhere in the world. The conversation also mentions treatments like Minoxidil, finasteride, and RU58841 for hairloss.
The conversation discusses a hairloss treatment regimen involving finasteride, dutasteride, spironolactone, bicalutamide, oral estradiol, microneedling, and minoxidil. The regimen aims to reduce androgenic alopecia by blocking DHT and androgens, with a caution about potential feminizing effects.
The conversation discusses a personalized hairloss treatment plan based on DNA test results, recommending Minoxidil, Dutasteride, 17-alpha Estradiol, Cetirizine, and PRP sessions. The test identifies a high risk of hairloss due to DHT but a good response to Minoxidil, suggesting a tailored approach to treatment.
Hairloss significantly impacts self-perception and attractiveness, with treatments like finasteride, minoxidil, and hair transplants suggested. The conversation highlights the emotional struggle and societal perceptions tied to hairloss.
A 21-year-old male with a thyroid condition noticed his hair thinning uniformly without a receding hairline. He is considering using a 5ARI to prevent further baldness if he starts TRT.
Lichen Planopilaris (LPP) is an autoimmune condition causing permanent hairloss and fibrosis, often misdiagnosed. Treatments include pioglitazone, topical corticosteroids, anti-inflammatory medication, and Jak inhibitors.
Balding seems to worsen with each generation, possibly due to stress, diet, and environmental factors. The user started treatments like Minoxidil and finasteride.
The emotional and psychological impact of hairloss in young people, how to cope with it, and potential treatments such as finasteride, RU58841, Minoxidil, SMP, and hair transplants.
Hair cloning technology is advancing, with clinical trials for improved methods expected by 2028 and 2029, potentially offering a solution for hairloss if donor follicles remain. Organtech's expansion into other biotech areas may secure funding, but the effectiveness of cloning depends on the availability of androgen-resistant donor follicles.
Hair cloning for hairloss is unlikely to be available or affordable in the next 10 years. Current treatments like Minoxidil, finasteride, and RU58841 are still the main options, with skepticism about new advancements.
The conversation discusses hairloss causes beyond male pattern baldness, mentioning treatments like ketoconazole, zinc shampoo, and finasteride. Stress-related hairloss (telogen effluvium) is also suggested.
A 25-year-old experiencing hair thinning all over the body and head, despite using minoxidil and having low vitamin D levels, is advised to seek a second opinion from a dermatologist specializing in hairloss. The likely diagnosis is diffuse alopecia areata, which may require treatment with a JAK inhibitor.
The conversation is about seeking updates on new hairloss treatments, specifically mentioning scube3 and GT20029, with one person mentioning HMI_115 as showing promising results.
Why androgenic alopecia affects the scalp rather than other body parts, potential explanations for this phenomenon, treatments available to combat hairloss, and the implications of male attractiveness in modern society.
A 22-year-old man shared his experience with hairloss, which began at age 20, and his treatment with finasteride and oral minoxidil, planning to add microneedling. Since experiencing hairloss, he has changed his perspective and now notices other men's hairloss more, viewing them positively, and others in the conversation relate to this shift in perception.
The conversation discusses hairloss treatments, specifically mentioning Minoxidil, finasteride, and RU58841. It also references Epibiotech's hair multiplication and cell therapy as potential solutions.
The user has tried various treatments for hairloss, including finasteride, dutasteride, RU58841, Pyrilutamide, and several topical growth factors, but continues to experience a receding hairline and thinning. Despite maintaining a healthy lifestyle, the user is unsure why these treatments are ineffective and seeks advice on the underlying cause.
The user experienced hairloss due to a crash diet and later developed scarring hairloss. They are now on finasteride, oral minoxidil, LDN, Zyrtec, and Oztela to reduce scalp inflammation and promote hair regrowth.
The user discusses their experience with hairloss despite taking estrogen and cyproterone, and estimates needing around 3000 grafts for a feminine hairline. They are considering getting the procedure done in Turkey due to high European costs.
CRISPR shows promise for treating hairloss by targeting specific genes. Current treatments include Minoxidil and finasteride, but CRISPR could offer a more precise solution, though it is still expensive and in early stages.
Researchers are working on regenerating hair follicles using stem cells, but a cure for baldness is still years away. Current treatments mentioned include Minoxidil, finasteride, and RU58841.
Treatments for hairloss, such as minoxidil, finasteride, and RU58841; humorous posts about hairloss; and the choice to stop using treatments in exchange for a different look.